BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16752942)

  • 1. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?
    Wolf HR
    Drugs R D; 2006; 7(3):163-72. PubMed ID: 16752942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers.
    Köhler S; Funk P; Kieser M
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):303-9. PubMed ID: 15166915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial.
    Gardner CD; Zehnder JL; Rigby AJ; Nicholus JR; Farquhar JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):787-93. PubMed ID: 17982321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ingestion of Ginkgo biloba extract (EGb 761) inhibits arachidonic acid-mediated platelet aggregation and thromboxane B2 production in healthy volunteers.
    Kudolo GB; Wang W; Barrientos J; Elrod R; Blodgett J
    J Herb Pharmacother; 2004; 4(4):13-26. PubMed ID: 15927922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers.
    Kim BH; Kim KP; Lim KS; Kim JR; Yoon SH; Cho JY; Lee YO; Lee KH; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2010 Feb; 32(2):380-90. PubMed ID: 20206795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, and acetylsalicylic acid.
    Hinder M; Frick A; Rosenburg R; Hesse G; Ozoux ML; Laux V; Scholtz H; Gebauer A; Paccaly A
    Thromb Haemost; 2006 Feb; 95(2):224-8. PubMed ID: 16493482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
    Fager G; Cullberg M; Eriksson-Lepkowska M; Frison L; Eriksson UG
    Eur J Clin Pharmacol; 2003 Aug; 59(4):283-9. PubMed ID: 12845508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts.
    Koch E
    Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H; Kieser M; Hölscher U
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding evaluation during single tooth extraction in patients with coronary artery disease and acetylsalicylic acid therapy suspension: a prospective, double-blinded, and randomized study.
    Medeiros FB; de Andrade AC; Angelis GA; Conrado VC; Timerman L; Farsky P; Dib LL
    J Oral Maxillofac Surg; 2011 Dec; 69(12):2949-55. PubMed ID: 21802823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment.
    Halil M; Cankurtaran M; Yavuz BB; Ozkayar N; Ulger Z; Dede DS; Shorbagi A; Buyukasik Y; Haznedaroglu IC; Arogul S
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):349-53. PubMed ID: 15970719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761).
    Kim YS; Pyo MK; Park KM; Park PH; Hahn BS; Wu SJ; Yun-Choi HS
    Thromb Res; 1998 Jul; 91(1):33-8. PubMed ID: 9700851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No alteration in platelet function or coagulation induced by EGb761 in a controlled study.
    Bal Dit Sollier C; Caplain H; Drouet L
    Clin Lab Haematol; 2003 Aug; 25(4):251-3. PubMed ID: 12890165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time.
    Ryu KH; Han HY; Lee SY; Jeon SD; Im GJ; Lee BY; Kim K; Lim KM; Chung JH
    Thromb Res; 2009 Jul; 124(3):328-34. PubMed ID: 19349067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of Campomanesia xanthocarpa in platelet aggregation: Comparison and synergism with acetylsalicylic acid.
    Otero JS; Hirsch GE; Klafke JZ; Porto FG; de Almeida AS; Nascimento S; Schmidt A; da Silva B; Pereira RLD; Jaskulski M; Parisi MM; Dos Santos Guarda N; Moresco RN; Aita CAM; Viecili PRN
    Thromb Res; 2017 Jun; 154():42-49. PubMed ID: 28410506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.